**No new pandemic is emerging in 2026, as reflected in the 89.5% market-implied probability for that outcome.** Global surveillance by the CDC, WHO, and national agencies shows no novel pathogen with sustained human-to-human transmission capable of causing a pandemic-scale event this year. COVID-19 has transitioned to endemic circulation at low levels, with Rt estimates near 1.0 and very low emergency-department visits. Recent localized outbreaks, such as Listeria linked to soft cheese and a hantavirus cluster on an Atlantic cruise ship in May 2026, remain contained; the latter has extremely low pandemic potential due to its rodent-to-human transmission mode and lack of efficient airborne spread. Ongoing monitoring of H5N1 avian influenza, mpox, and other priority pathogens shows no signs of rapid escalation or variant emergence that would meet pandemic criteria. Enhanced preparedness frameworks post-COVID, including improved genomic sequencing and early-warning systems, further support trader consensus that a new pandemic is unlikely before year-end, though unpredictable zoonotic jumps or mutations remain inherent uncertainties in infectious-disease dynamics.